Disclosures: Mitchell Edwards: Nothing to Disclose, Austin Ma: Nothing to Disclose, Rakan Alqahtani: Nothing to Disclose, Erin Kelly: Nothing to Disclose, Neta Gotlieb: Nothing to Disclose, Pearl Tan: Nothing to Disclose, Maryam Moini: Nothing to Disclose, Fernanda de Quadros Onofrio: Nothing to Disclose, Natalie Trudel: Nothing to Disclose, Jose-Anne Lamoureux: Nothing to Disclose, Angela Cheung: Nothing to Disclose 2179 PARACENTESIS EXCEEDING THREE LITERS INCREASES RISKS OF ACUTE KIDNEY INJURY EVEN IN CIRRHOTIC PATIENTS WITH ALBUMIN INFUSED REFRACTORY ASCITES Peishan Wu 1 Kuei-Chuan Lee 1 Chih-Yu Li 1 Yun-Cheng Hsieh 1 Teh-Ia Huo 1 Han-Chieh Lin 1 Ming-Chih Hou 1 , 1 Taipei Veterans General Hospital Background: Refractory ascites in cirrhotic patients presents a challenging clinical problem, marked by severe portal hypertension and significant hemodynamic disturbances
Communities near sites like New Yorks Seneca Army Depot, where PFAS has leaked into local water sources such as Seneca Lake, are pushing for swift remediation to protect their water supplies
Work with your provider to ensure appropriate ongoing thyroid monitoring based on your specific condition
Though early work from companies like Vertex (Semma Tx acquisition) are focused on regeneration of pancreatic islets (for diabetes), Novo Nordisk recently inked a deal (including $75M upfront) with early-stage cell therapy player Aspect Biosystems
GLP-1 receptor agonists differ in their structural similarity to native human GLP-1, with some being modified peptides and others being exendin-4 analogues
